Ferric Gluconate Reduces Epoetin Requirements in Hemodialysis Patients with Elevated Ferritin

The Dialysis Patients Response to IV Iron with Elevated Ferritin (DRIVE) study demonstrated the efficacy of intravenous ferric gluconate to improve hemoglobin levels in anemic hemodialysis patients who were receiving adequate epoetin doses and who had ferritin levels between 500 and 1200 ng/ml and t...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Kapoian, Toros, O'Mara, Neeta B., Singh, Ajay K., Moran, John, Rizkala, Adel R., Geronemus, Robert, Kopelman, Robert C., Dahl, Naomi V., Coyne, Daniel W.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society of Nephrology 2008
Pynciau:
Clinical Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC2396742/
https://ncbi.nlm.nih.gov/pubmed/18216316
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2007050606
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg